# The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers

> **NCT01591083** · PHASE4 · COMPLETED · sponsor: **National Cheng-Kung University Hospital** · enrollment: 474 (actual)

## Conditions studied

- Peptic Ulcer Bleeding

## Interventions

- **DRUG:** esomeprazole (Nexium®, AstraZeneca AB, Södertälje, Sweden)

## Key facts

- **NCT ID:** NCT01591083
- **Lead sponsor:** National Cheng-Kung University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2014-07
- **Final completion:** 2014-07
- **Target enrollment:** 474 (ACTUAL)
- **Last updated:** 2015-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591083, "The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01591083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*